GLP-1RAs, which are approved to treat type 2 diabetes, obesity, and obstructive sleep apnea, are now being investigated for their effects on processes involving appetite and satiety, reward processing, stress regulation, cognition, and neuroinflammation
Tonnus, W
Neither compound has been associated with significant cortisol, prolactin, or aldosterone elevation distinguishing them from older GHRPs
& Szarka, A
[9] Further research on Ipamorelin suggests the possibility of anabolic actions, particularly in the sense that it may help restore nitrogen balance and reduce nitrogen wasting in the liver of rats exposed to catabolic agents
Steady, Sustained Weight Loss: Many patients can expect to lose as much as ten pounds within four to six weeks of starting their weight loss program